Age-dependence of healthcare interventions for COVID-19 in Ontario, Canada

Irena Papst1, Michael Li2,3, David Champredon4

  • 1Center for Applied Mathematics, Cornell University, Ithaca, USA. ip98@cornell.edu.

BMC Public Health
|April 13, 2021
PubMed

Insights

COVID-19 hospitalizations significantly impact middle-aged and younger seniors, not just the elderly. Vaccination strategies should target these groups to prevent serious illness and reduce healthcare system strain.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Diseases

Background:

  • Patient age is a critical risk factor for COVID-19 severity.
  • While COVID-19 deaths are concentrated in older populations, less is known about age distributions for serious medical interventions.
  • Understanding these distributions is crucial for healthcare system planning and vaccination strategies.

Purpose of the Study:

  • To quantify the relationship between COVID-19 patient age and serious medical outcomes, including hospitalizations and intensive care.
  • To analyze the age-specific probabilities of hospitalization and survival following COVID-19 infection.

Main Methods:

  • Analysis of 277,555 SARS-CoV-2 infection records in Ontario, Canada (Jan 2020 - Feb 2021).
  • Estimation of age distributions for hospitalizations, ICU admissions, intubations, and ventilations.
  • Calculation of hospitalization probability given infection and survival probability given hospitalization.

Main Results:

  • Hospitalizations peak in a broad range from ages 60-90, contrasting with deaths concentrated in ages 80+.
  • The probability of hospitalization reaches 27.8% at age 80.
  • Survival probability after hospitalization declines significantly after age 40, with a 54-year-old having a 91.7% chance of survival.

Conclusions:

  • Middle-aged individuals and younger seniors show a significant need for hospitalization, a trend not evident from death distributions alone.
  • COVID-19 survival rates post-hospitalization are lower than often perceived for individuals over 40.
  • Vaccination efforts should extend beyond the elderly to include middle-aged and younger seniors to mitigate serious illness and healthcare system burden.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
72
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
61
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
66
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
119
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
50
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
60